Don Vaughn, Ph.D., is a neuroscientist and entrepreneur whose work in neurotechnology and brain science has been featured by ABC, ESPN, TIME, and The Economist. His TEDx talk, “Neurohacking: Rewiring Your Brain,” has been viewed more than one million times. He earned degrees from @Stanford and a PhD in Neuroscience from @UCLA. @DrDonVaughn is co-founder and CEO of Ampa, advancing breakthroughs in mental health and brain function through neuroscience and artificial intelligence. Ampa was one of 16 companies selected for the 2025 One Mind Accelerator cohort. Since participating, the company has continued scaling its technology, launching a nationwide rollout of its portable, FDA-cleared brain stimulation system following an oversubscribed $8.5M funding round. The One Mind Accelerator supports founders tackling one of the world’s most complex challenges: mental illness, combining small mission-aligned cohorts with direct access to leaders across neuroscience, health systems, venture capital, and industry. With 51 companies in the portfolio, @OMAccelerator is catalyzing a new generation of mental health innovation. Learn more at onemindaccelerator.com #MentalHealth #Innovation #HealthCare #OneMind #Accelerator #MentalHealthAwarenessMonth #MHAM2026 #MentalHealthMonth

Supriya Laknidhi is a healthcare entrepreneur and operator with 15+ years of experience across product, operations, and strategy at some of the country's leading health organizations. She holds a BS from @UMich and an MBA from @NorthwesternU's @KelloggSchool. Her career has spanned roles at @CVSHealth, @Aetna, and The Boston Consulting Group (@BCG), before she went on to serve as COO at Bend Health (@hellobendhealth). Supriya is co-founder and CEO of Cerula Care, the first cancer-focused collaborative behavioral health and care navigation company, seamlessly integrating with oncology practices to provide personalized, virtual-first support to improve health outcomes for people living with cancer. Cerula Care was one of 10 companies selected for the 2024 One Mind Accelerator cohort. Since participating, the company has continued to grow, closing an oversubscribed $3.7 million Seed round led by Esplanade Ventures, with participation from @amplify_cap, @brightedge, @DigiTx_Partners, SpringTime Ventures, and Mike Pykosz, former CEO & co-founder of @OakStreetHealth. The One Mind Accelerator supports founders tackling one of the world’s most complex challenges: mental illness, combining small mission-aligned cohorts with direct access to leaders across neuroscience, health systems, venture capital, and industry. With 51 companies in the portfolio, @OMAccelerator is catalyzing a new generation of mental health innovation. Learn more at onemindaccelerator.com #MentalHealth #Innovation #HealthCare #OneMind #Accelerator #MentalHealthAwarenessMonth #MHAM2026 #MentalHealthMonth

🧠 Fort Health is tackling one of the most urgent—and underserved—crises in mental health: access to care for kids and teens. Their goal: No child should wait months to get the mental health support they need. Fort Health joined the One Mind Accelerator to refine the company’s pediatric telehealth model, expand partnerships with payers, and embed lived experience into platform design. Applications for the 2026 session are now being accepted. Learn more and apply at onemindaccelerator.org #MentalHealth #Startups #Pediatrics #Telehealth #CareAccess #Founders #2026OMA

ATTENTION FOUNDERS in #MentalHealth #Innovation! 🚀 Applications for the 2026 One Mind Accelerator will be accepted starting 9/2 through 11/10! In advance of the launch, we're hosting a webinar tomorrow, 8/26 @ 12p PT / 3p ET. ​Register here: lu.ma/r7jdjdrk You'll hear directly from the following 4 alumni from the program: 🌟 ​Supriya Laknidhi, Founder & CEO of Cerula Care ​🌟 Philip Strandwitz, Founder & CEO, @Holobiome_Inc ​🌟 Mark Jacobstein, Co-Founder & President, Jimini Health ​🌟 Lilianne Mujica-Parodi, Co-Founder & CEO, @neuroblox Learn more at onemind.org/OMA #OneMind #Accelerator #Startups #BrainHealth

Function Health—a 2024 @OMAccelerator company—has been recognized in @TIME's List of 100 Most Influential Companies of 2025! Co-Founded by CEO Jonathan Swerdlin, @function is a personal health co-pilot that starts with understanding your body through all-in-one lab testing. Function’s membership includes 100+ advanced lab tests, with results delivered alongside easy-to-read, actionable insights developed with the world’s top doctors. Read more: time.com/collections/time100…

🚀 The 2025 One Mind Accelerator (@OMAccelerator) wrapped its closing week with an inspiring three-day series of founder stories, expert panels, collaborative roundtables, and a powerful #DemoDay that showcased the future of #MentalHealth innovation.

🚀 MEET THE #2025OMA COHORT:⁠ @Xylo_Bio Xylo’s mission is to deliver transformative therapies that integrate seamlessly into existing healthcare systems, making these innovations accessible to a greater number of patients in need. Founded by @joshismin & Dr. Samuel Banister (@samuel_b_phd), Xylo evolved from psychedelic-inspired research into a neuroscience-focused biotech, now advancing its lead asset, XYL-1001, toward clinical development. By enhancing neuroplasticity, Xylo addresses underlying dysfunctions instead of merely managing symptoms, paving the way for long-term recovery. ⁠ To learn more, visit xylo.bio #MentalHealth #Neuroscience #Biotech #Accelerator #Innovation

🚀 Meet the #2025OMA Cohort: TownHome Health TownHome is building the first scalable model for Behavioral Crisis Care; this is a proven solution for the ~2M non-dangerous BH crises per year across the US. Co-founded by Charles Raisch (tech exec turned mental health advocate) & Dr. Donna Friedman (who led NYC’s largest BH crisis program for 11 years), TownHome provides specialized care for patients often underserved in hospitals.⁠ ⁠ About 30% of BH crisis patients qualify for TownHome's Crisis Program. Compared to the average hospital patient, these crisis patients: stay longer, cost more, experience higher levels of unnecessary trauma, & create burdens for hospital staff. As a result, hospitals are eager to partner with TownHome to provide a turn-key solution—current partners include the @MayoClinic, @NYCHealthSystem, @MountSinaiNYC, & many more. TownHome is redefining what effective, compassionate crisis care looks like.⁠ Learn more at townhomehealth.com

🚀 MEET THE #2025OMA COHORT:⁠ @slingshotai_inc Slingshot AI is a research lab building the foundation model for #psychology. Slingshot is developing the first AI to scale access to mental health care. Through partnerships with a consortium of mental health organizations, they train a language model to understand the mental health journeys of a vast and diverse population and the range of therapeutic approaches. As a result, their model learns to support people across a range of therapeutic modalities, including CBT/DBT, ACT, IFS, & psychodynamic #therapy. And by deploying their model, Slingshot aims to learn what works, at scale, for the first time. Slingshot’s founding team includes Daniel Reid Cahn, an ML Researcher who focused on AI for mental health crisis support; Neil Parikh (@npparikh), co-founder of IPO’d consumer sleep brand, @Casper; @derrickhull, who led clinical research and practice at organizations like @talkspace, @noom, & @HeroJourneyClub; and a team of mission-driven engineers who have worked on mental health, privacy, trust & safety, elder care, & healthcare across a wide range of populations. Learn more at slingshot.xyz

🚀 MEET THE #2025OMA COHORT:⁠ Sanmai⁠ ⁠ Sanmai is a neurotechnology company pioneering precision-focused, non-invasive ultrasound neurotherapeutics to transform mental health and neurological care. ⁠ ⁠ By integrating transcranial ultrasound stimulation with AI-driven software, Sanmai’s flagship device, Lotus, will offer a safe and effective alternative for conditions like anxiety, depression, and other neurological disorders.⁠ ⁠ Led by Drs. Jay Sanguinetti, Taylor Kuhn, and Jud Brewer, Sanmai’s team brings a wealth of expertise in neuroscience, clinical research, and mental health innovation.⁠ ⁠ Sanmai envisions a world where people can access safe, effective mental health treatments that empower their path to well-being and autonomy.⁠ #Neuroscience #MentalHealth #Innovation #Research #Ultrasound #Neurotherapeutics

🚀 MEET THE #2025OMA COHORT:⁠ @MindstateDesign Mindstate Design Labs is a techbio platform & psychiatric therapeutics company that is repurposing the mechanisms of #psychedelics to deliver transient psychoactive states & targeted reintegrations of neural connectivity. Mindstate Design Labs, a @ycombinator company that raised a seed round led by @Initialized Capital with participation from other venture funds & angels including founders of @OpenAI & @neuralink, was founded by biotech venture investor @DillanDiNardo & evolutionary biologist & computer scientist Dr. Thomas Ray, creator of the first self-evolving artificial life program & collaborator of “godfather of psychedelics” #AlexanderShulgin. Mindstate Design Labs' mission is to transform the mental health crisis by enabling the safe, consistent delivery of novel psychoactive effects. Learn more at mindstate.design

🚀 MEET THE #2025OMA COHORT:⁠ Metabolic Psychiatry Labs⁠ ⁠ Metabolic Psychiatry Labs (MPL) treats serious mental illness with precision through food, real-time data, & expert virtual care. Using a @Stanford-backed proprietary protocol developed by CEO & Founder Dr. Shebani Sethi (@ShebaniMD), MPL combines evidence-based #nutrition & metabolic therapeutic approaches to address underlying dysfunctions like inflammation, oxidative stress, & insulin resistance.⁠ ⁠ Specializing in #Schizophrenia, #BipolarDisorder, #MajorDepression, and select #EatingDisorders , MPL employs #AI & #MachineLearning to support clinicians & integrate its methods into other institutions. The approach has demonstrated proven outcomes, including reversal of metabolic syndrome, an average 10% weight loss, & clinical symptom improvement in 79% of patients.⁠ ⁠⁠ By focusing on patient-centric innovation & leveraging advanced #technology, MPL is committed to providing a path to sustained wellness and improved quality of life, establishing itself as a leader in metabolic #psychiatry services.⁠ ⁠ Learn more⁠ at metabolicpsychiatrylabs.com

🚀 MEET THE #2025OMA COHORT:⁠ LunaJoy Health LunaJoy is the leading provider of women’s mental health services. Their innovative care model offers integration between screening, primary care and access to a specialized workforce to meet women where they are at through various life transitions including pregnancy and postpartum. LunaJoy’s services encompass therapy, medication management, coaching, and wellness tools, all tailored to address specific challenges such as anxiety, depression, infertility, perinatal and postpartum issues, menopause, and other life transitions. Through partnerships with national payers and providers, LunaJoy Health’s mission is to bring accessible care directly to women in the places that they receive their healthcare and shift the model from reactive and crisis based generalized care to personalized, predictive and preventative. LunaJoy is led by Co-Founder & CEO Sipra Laddha, MD and Co-Founder Shama Rathi, MD. Learn more at hellolunajoy.com ⁠⁠ #Innovation #MentalHealth #Women #OneMind #Accelerator

🚀 MEET THE #2025OMA COHORT:⁠ Jimini Health Jimini’s mission is to radically improve the efficacy of mental health care worldwide. It has developed a novel care model that combines teletherapy sessions with personalized AI support. With Jimini, the therapy care team includes a licensed clinician and Sage, the always-available AI therapy assistant, who work together to help individuals achieve their goals. Co-Founded in 2023 by CEO Luis Voloch and Chief Product Officer Sahil Sud—Jimini uses science and tech to put patients first. Jimini’s safe, purpose-built technology works exclusively under clinical oversight and with high safety standards. Jimini is committed to improving mental health quality and creating radically better, more modern, and clinically efficacious mental health experiences for patients. Learn more at jiminihealth.com #MentalHealth #Teletherapy #Therapy #HealthCare #Psychology #OneMind #Accelerator

🚀 MEET THE #2025OMA COHORT:⁠ Humanity Neurotech Led by Founder and CEO Dr. Blake Gurfein (@BGurfein), PhD, and Founding Head of Product, David Maltz, Humanity Neurotech has developed a groundbreaking, noninvasive device, called microtesla magnetic therapy (MMT), that delivers low amplitude radiofrequency magnetic fields to the brain. MMT is designed to deliver therapy to both superficial and deep brain structures and rapidly promotes mitochondrial renewal and resolution of inflammation – two significant therapeutic goals in developing new treatments for brain disorders. MMT is now being tested in a population of patients with cognitive impairment from Long Covid, also called Neuro-PASC. A first in human clinical trial, led by Dr. David Putrino, is currently underway at the Cohen Center for Recovery from Complex Chronic Illness at The Mount Sinai Hospital in New York City. Additional clinical areas of interest include Schizophrenia, Bipolar Disorder, Post-concussion Syndrome, and Parkinson’s disease. Learn more at humanityneurotech.com #OneMind #Accelerator #Neuroscience #Innovation #MentalHealth #LongCovid⁠

🚀 MEET THE #2025OMA COHORT:⁠ @FreedomBioInc ⁠ Co-Founded by CEO Dina Burkitbayeva and Chief Scientific Advisor Dr. John Krystal, MD, Freedom Biosciences is a Yale spin-out and clinical-stage biotech platform developing next generation ketamine-based and neuropsychiatric pharmaceuticals to develop more viable and efficacious treatment alternatives for people struggling with debilitating mental health disorders. ⁠⁠ Freedom Biosciences's lead program Free001 (“extended efficacy ketamine”) is based on a Yale study that showed 3-4x longer duration of antidepressant effect than ketamine & esketamine: 14-21 days in antidepressant effects vs. 2-7 days for racemic ketamine and esketamine (published in Nature). Learn more at freedombio.co

🚀 MEET THE #2025OMA COHORT:⁠ Fort Health⁠ Fort Health is a pioneering mental health company dedicated to transforming care for children, adolescents, & their families. Founded in collaboration with the @childmindinst, Fort Health leverages decades of clinical expertise & research to deliver exceptional care tailored to young people aged 4 to 24.⁠ By combining evidence-based treatments, innovative technology, & insurance-based models, Fort Health makes high-quality mental health services more accessible & affordable for families navigating challenges such as anxiety & depression.⁠ Led by CEO & Founder, Natalie Schneider & Founding Clinical Director, Lindsay Henderson, Fort Health is on a mission to close the gap in access to pediatric mental health care. Through compassion, expertise, & innovation, the company is redefining how mental health care is delivered, one family at a time.⁠ Learn more at forthealth.com #OneMind #Accelerator #Innovation #HealthCare #MentalHealth #Children #Family

🚀 MEET THE #2025OMA COHORT:⁠ @deliberate_ai ⁠ Led by Founder & CEO, Marc Aafjes, Deliberate AI's mission is to create a future where mental health care is proactive, personalized, & profoundly effective.⁠ The company empowers clinicians with tools for earlier, simpler, & more effective assessments, as well as continuous monitoring of treatment responses.⁠ ⁠ Deliberate AI's flagship model, AI-COATM (AI-driven Clinical Outcome Assessment) for depression and anxiety, was accepted into the FDA’s ISTAND pilot program in 2024 as its first AI and first neuroscience project, pioneering a new era of objective tools in psychiatry.⁠ ⁠ ⁠ By seamlessly integrating audiovisual, behavioral, & physiological data collected during clinical encounters or remotely through AI agents, Deliberate AI is working to deliver data-driven insights that outperform traditional approaches & set new standards in mental health.⁠ ⁠⁠ #OneMind #Accelerator #MentalHealth #Technology #Innovation #Psychiatry #Neuroscience